SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-130561
Filing Date
2023-05-01
Accepted
2023-05-01 16:37:01
Documents
17
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d458489d10ka.htm   iXBRL 10-K/A 409114
2 EX-31.3 d458489dex313.htm EX-31.3 3827
3 EX-31.4 d458489dex314.htm EX-31.4 3750
9 GRAPHIC g458489g0501200647442.jpg GRAPHIC 13946
  Complete submission text file 0001193125-23-130561.txt   693708

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA urgn-20221231.xsd EX-101.SCH 4965
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20221231_cal.xml EX-101.CAL 667
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20221231_def.xml EX-101.DEF 1672
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20221231_lab.xml EX-101.LAB 20890
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20221231_pre.xml EX-101.PRE 16746
11 EXTRACTED XBRL INSTANCE DOCUMENT d458489d10ka_htm.xml XML 7974
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38079 | Film No.: 23874350
SIC: 2834 Pharmaceutical Preparations